MAOIs can cause hypertensive crisis when consumed with foods containing tyramine due to drug-food interactions. Enzyme-inducing drugs like rifampicin may cause vitamin deficiencies by inducing metabolism of vitamins. Orlistat and bile acid sequestrants can decrease absorption of fat-soluble vitamins. Some foods contain substances that can act on the same receptors as drugs, producing agonistic or antagonistic effects. A high protein diet can decrease absorption of l-dopa into the central nervous system through competition at the blood-brain barrier. Grapefruit juice interacts with many drugs by inhibiting cytochrome P450 enzymes in the gut wall.
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0 ratings0% found this document useful (0 votes)
103 views1 page
Drug Interaction
MAOIs can cause hypertensive crisis when consumed with foods containing tyramine due to drug-food interactions. Enzyme-inducing drugs like rifampicin may cause vitamin deficiencies by inducing metabolism of vitamins. Orlistat and bile acid sequestrants can decrease absorption of fat-soluble vitamins. Some foods contain substances that can act on the same receptors as drugs, producing agonistic or antagonistic effects. A high protein diet can decrease absorption of l-dopa into the central nervous system through competition at the blood-brain barrier. Grapefruit juice interacts with many drugs by inhibiting cytochrome P450 enzymes in the gut wall.
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 1
drug interactions drug-food
Effects of drugs on food
MAOIs cause the cheese reaction withtyramine-containing foods causing a hypertensivecrisis Enzyme inducers (rifampicin, anticonvulsants) may induce the metabolism of vitamin D and folate causing respective deficiencies. Orlistat and bile-acid sequestrants maydecrease the absorption of fat-soluble vitamins(A, D, E, K). Stimulant laxatives (senna, biscodyl) anddiuretics may cause electrolyte losses altered drug effects liquorice vitamin K ethanol Some foods contain substances that act on the same receptors or sites of action as drugs. Agonistic or antagonistic effects may be observed. clearance high protein diet decreases the uptake of l-dopa into the CNS by competition between amino acids and l-dopa at the bloodbrain barrier. distribution high protein diet decreases the uptake of l-dopa into the CNS by competition between amino acids and l-dopa at the bloodbrain barrier. grapefruit juice amlodipine lovastatin atorvastatin midazolam buspirone nifedipine carbamazepine nimodipine cisapride saquinavir cyclosporin simvastatin diltiazem tacrolimus ethinyloestradiol triazolam felodipine verapamil first-pass metabolism In general, food increases liver blood flow from the gut causing increased extent of availability of drugs subject to high first-pass metabolism (see absorption Iron, calcium and other divalent or trivalent ions (e.g. dairy products or in supplements) may chelate some drugs decreasing extent of absorption, e.g. quinolones and tetracyclines are chelated by antacids, and by calcium in milk. Stimulation ofgastric enzymes and acid may degrade somedrugs, e.g. flucloxacillin. Food may decrease the extent of absorption, particularly of polar, hydrophilic, lipid insoluble drugs, e.g. atenolol drug-drug drugs with important interactions antiarrhythmics cause enzyme inhibition cyclosporin anticonvulsants cause enzyme induction digoxin anticoagulants multiple mechanisms hypoglycaemic agents antidepressants cause enzyme inhibition lithium protease inhibitors cause enzyme inhibition theophylline Pharmacodynamic examples MOA inhibitors enhances ephedrine effects b-blockers and b2-agonists Drug effect is altered through receptor, cellular or other physiological mechanisms. Enhancement or antagonism may occur. e.g. !-agonist/!-blocker-mutual competition at receptor site. Pharmaceutic Physicochemical interactions may occur prior to systematic availability e.g. inactivation of phenytoin within IV giving sets if pH is <7.0. Pharmacokinetic Altered elimination Renal excretion reduced prostaglandin synthesis in kidney through NSAIDs, decreasing renal blood flow and less antihypertensive effect of diuretics Competition for ionic cotransporte.g. Li+/Na+ " Li+ accumulation withdiuretics. Competition for active secretion in proximaltubulee.g. probenecid/penicillin "$[penicillin] Altered pH of urinee.g. HCO!aspirin excretion Enzyme inhibition in the presence of amiodarone, the plasma concentration of metoprolol is higher than would normally be expected Enzyme induction Interactions may occur at metabolic or renal sites of elimination. Metabolic interactions include enzyme induction or inhibition. These happen especially with drugs metabolized by cytochrome-P450-mediated metabolism Altered availability carbidopa is a drug used in conjunction with levodopa (L-dopa) in the treatment of Parkinsons disease. L-Dopa, which is converted to dopamine in the body, can cross the bloodbrain barrier. Carbidopa prevents the conversion of L-dopa to dopamine; however, it cannot cross the bloodbrain barrier and so acts to reduce the peripheral side-effects while still allowing the desired effects of the drug. Altered bacterial florae.g. antibiotics/sulphasalazine " # cleavageof sulphasalazine in large intestine. Altered first-pass metabolisme.g. oestrogens/ascorbic acid " $[oestrogen Altered motilitye.g. metoclopramide/digoxin " #[digoxin] Chelation within the gute.g. tetracyclines/Ca2+"#[tetracycline